Hinderlich S - Search Results

1

In Vitro Evaluation of Glycoengineered RSV-F in the Human Artificial Lymph Node Reactor.

Radke L, Sandig G, Lubitz A, Schließer U, von Horsten HH, Blanchard V, Keil K, Sandig V, Giese C, Hummel M, Hinderlich S, Frohme M. Radke L, et al. Among authors: hinderlich s. Bioengineering (Basel). 2017 Aug 15;4(3):70. doi: 10.3390/bioengineering4030070. Bioengineering (Basel). 2017. PMID: 28952549 Free PMC article.

2

Engineering of CHO Cells for the Production of Recombinant Glycoprotein Vaccines with Xylosylated N-glycans.

Sandig G, von Horsten HH, Radke L, Blanchard V, Frohme M, Giese C, Sandig V, Hinderlich S. Sandig G, et al. Among authors: hinderlich s. Bioengineering (Basel). 2017 Apr 28;4(2):38. doi: 10.3390/bioengineering4020038. Bioengineering (Basel). 2017. PMID: 28952517 Free PMC article.

3

Applying Acylated Fucose Analogues to Metabolic Glycoengineering.

Rosenlöcher J, Böhrsch V, Sacharjat M, Blanchard V, Giese C, Sandig V, Hackenberger CPR, Hinderlich S. Rosenlöcher J, et al. Among authors: hinderlich s. Bioengineering (Basel). 2015 Nov 30;2(4):213-234. doi: 10.3390/bioengineering2040213. Bioengineering (Basel). 2015. PMID: 28952479 Free PMC article.

4

The human rhabdomyosarcoma cell line TE671--Towards an innovative production platform for glycosylated biopharmaceuticals.

Rosenlöcher J, Weilandt C, Sandig G, Reinke SO, Blanchard V, Hinderlich S. Rosenlöcher J, et al. Among authors: hinderlich s. Protein Expr Purif. 2015 Nov;115:83-94. doi: 10.1016/j.pep.2015.08.008. Epub 2015 Aug 10. Protein Expr Purif. 2015. PMID: 26272370

5

Recombinant glycoproteins: The impact of cell lines and culture conditions on the generation of protein species.

Rosenlöcher J, Sandig G, Kannicht C, Blanchard V, Reinke SO, Hinderlich S. Rosenlöcher J, et al. Among authors: hinderlich s. J Proteomics. 2016 Feb 16;134:85-92. doi: 10.1016/j.jprot.2015.08.011. Epub 2015 Aug 24. J Proteomics. 2016. PMID: 26316330

6

The analysis of N-glycans of cell membrane proteins from human hematopoietic cell lines reveals distinctions in their pattern.

Reinke SO, Bayer M, Berger M, Hinderlich S, Blanchard V. Reinke SO, et al. Among authors: hinderlich s. Biol Chem. 2012 Aug;393(8):731-47. doi: 10.1515/hsz-2012-0195. Biol Chem. 2012. PMID: 22944676

7

Bioengineering of rFVIIa Biopharmaceutical and Structure Characterization for Biosimilarity Assessment.

Montacir O, Montacir H, Eravci M, Springer A, Hinderlich S, Mahboudi F, Saadati A, Parr MK. Montacir O, et al. Among authors: hinderlich s. Bioengineering (Basel). 2018 Jan 19;5(1):7. doi: 10.3390/bioengineering5010007. Bioengineering (Basel). 2018. PMID: 29351237 Free PMC article.

8

Glycan-specific metabolic oligosaccharide engineering of C7-substituted sialic acids.

Möller H, Böhrsch V, Bentrop J, Bender J, Hinderlich S, Hackenberger CP. Möller H, et al. Among authors: hinderlich s. Angew Chem Int Ed Engl. 2012 Jun 11;51(24):5986-90. doi: 10.1002/anie.201108809. Angew Chem Int Ed Engl. 2012. PMID: 22674889 No abstract available.

9

Inhibition of the key enzyme of sialic acid biosynthesis by C6-Se modified N-acetylmannosamine analogs.

Nieto-Garcia O, Wratil PR, Nguyen LD, Böhrsch V, Hinderlich S, Reutter W, Hackenberger CPR. Nieto-Garcia O, et al. Among authors: hinderlich s. Chem Sci. 2016 Jun 1;7(6):3928-3933. doi: 10.1039/c5sc04082e. Epub 2016 Feb 19. Chem Sci. 2016. PMID: 30155038 Free PMC article.

10

Chemoselective labeling of engineered fucosylated glycoproteins.

Hackenberger CP, Hinderlich S. Hackenberger CP, et al. Among authors: hinderlich s. Chembiochem. 2007 Oct 15;8(15):1763-5. doi: 10.1002/cbic.200700417. Chembiochem. 2007. PMID: 17768729 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page